Pascua, Philippe Noriel Q <br/><br/>
Optimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model.  [electronic resource] 

 -  The Journal of antimicrobial chemotherapy  05 2019 
 - 1333-1341 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2091 
<br/><br/><label>Standard No.: </label>10.1093/jac/dky560  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Amides--administration & dosage<br/>Animals<br/>Antiviral Agents--administration & dosage<br/>Disease Models, Animal<br/>Dogs<br/>Epithelial Cells--virology<br/>Female<br/>Immunocompromised Host<br/>Influenza B virus--drug effects<br/>Madin Darby Canine Kidney Cells<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, SCID<br/>Orthomyxoviridae Infections--drug therapy<br/>Pyrazines--administration & dosage<br/>Viral Load--drug effects<br/>Virus Replication--drug effects